Dr. Trinanjan Basu

Dr. Trinanjan Basu is a reputed Medical Oncologist in Mumbai with more than 20 years of experience in this field. He is currently practicing as a Senior Consultant at HCG Centre – Borivali, Mumbai. He has technical expertise in SRS, and SBRT with a dedicated program for recurrent head-neck cancer SBRT, Prostate SBRT, and Lung SBRT (Linac-based and Cyberknife). 

Specialization

Dr. Trinanjan Basu has medical expertise in the following specialty areas –

• Benign and malignant brain tumors
• Head and neck cancers with IMRT/VMAT
• Application of SRS/SBRT in brain
• Spine
• Lung and Prostate Malignancies

Education

• MBBS from Calcutta University R.G.Kar Medical College, Calcutta in 2004

• Doctor of Medicine (MD) from West Bengal University of Health Sciences IPGMER in 2010

Experience

Dr. Trinanjan Basu has rich experience in PET-CT-based treatment planning and evaluation for head & neck malignancies – an advanced technique to spare normal structures to assess and improve a patient’s overall quality of life. His future goals and aspirations include analyzing and documenting contemporary imaging-based outcome analysis (PET-CT and MRI) for diverse cancer sites and PETCT and MRI-based Radiomics data and MRI Linac-based treatment. He has gained immense proficiency and skilled competency by working in various hospitals and centers from –

• 2010 – 2012 Senior registrar-radiation oncology, TMH. at Tata Memorial Hospital, Mumbai.
• 2012 – 2013 Clinical associate-radiation oncology at Kokilaben Dhirubhai Ambani Hospital, Mumbai.
• 2013 – 2017 Associate consultant-radiation oncology at Medanta The Medicity
• 2017 – 2017 Consultant radiation oncologist at HCG Apex Cancer Centre

Membership

• European Society Of Medical Oncology (ESMO)
• European Society For Radiotherapy & Oncology (ESTRO)
• Association Of Radiation Oncologists Of India (AROI)

Publications

Dr. Trinanjan Basu has more than 90 national and international publications. Some of the few recent publications of him are –

[Commentary] SBRT (Stereotactic Body Radiotherapy) in Recurrent Head Neck Cancer – Boon or Bane?

Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy

Towards a comprehensive head‑and‑neck oncological radiology (HNOR) consortium: Are we there yet?

Safety, Efficacy and Quality of Life with Stereotactic Radiotherapy (SBRT) in High Risk, Node Positive and Oligometastatic Prostate Cancers

Multi-Institutional Clinical Outcomes of Biopsy Gleason Grade Group 5 Prostate Cancers Treated With Contemporary High-Dose Radiation and Long-Term Androgen Deprivation Therapy

Simultaneous integrated boost (SIB) stereotactic body radiotherapy (SBRT) for prostate and pelvic nodes in high risk, node positive and oligometastatic prostate cancers: Safety, efficacy and quality of life outcome measures.

Stereotactic Body Radiotherapy and Immunotherapy for Older Patients with Oligometastases: A Proposed Paradigm by the International Geriatric Radiotherapy Group

Awards and Recognitions

• ESTRO Mobility Grant, Paris, France – 2016
• Neil Joseph Award, Mumbai. – 2010

Registrations

• 2017073640 Maharashtra Medical Council, 2017